List of works by Prashant Kapoor

A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing

scientific article published on 13 February 2019

A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy

scientific article published on 23 February 2017

A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis

scientific article published on 23 July 2020

Analysis of Clinical Factors and Outcomes Associated with Non-Utilization of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant Eligible Patients with Multiple Myeloma.

scientific article published on 12 April 2018

Another bidder (BDR) revisits.

scientific article

Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis

scholarly article by M Hasib Sidiqi et al published March 2019 in Biology of Blood and Marrow Transplantation

Autologous Stem Cell Transplant for Immunoglobulin Light Chain Amyloidosis Patients Aged 70 to 75

scientific article published on 20 June 2018

Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agents

scientific article published on 04 December 2020

Autologous stem cell transplantation in immunoglobulin light chain amyloidosis with factor X deficiency

scientific article published on 25 July 2015

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

scientific article published on 03 April 2018

Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation

scientific article published on 12 October 2016

Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma

scientific article published on 28 August 2020

Characteristics of long-term survivors with multiple myeloma: A National Cancer Data Base analysis

scientific article published on 28 June 2019

Characterization and prognostic implication of delayed complete response in AL amyloidosis

scientific article published on 23 November 2020

Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathies.

scientific article published on 5 May 2016

Clinical and prognostic differences among patients with light chain deposition disease, myeloma cast nephropathy and both.

scientific article published on 12 May 2015

Clinical characteristics and outcomes in biclonal gammopathies

scientific article published on 3 February 2016

Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities

scientific article published on 01 August 2020

Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis

scientific article published on 05 March 2019

Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia

scientific article published on 29 March 2017

Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis

scientific article published on 21 October 2013

Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatment

scientific article published on 06 October 2020

Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myeloma.

scientific article published on 16 August 2018

Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis

Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients

scientific article published on 11 December 2020

Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy

scientific article published on 09 October 2019

Delayed neutrophil engraftment in patients receiving Daratumumab as part of their first induction regimen for multiple myeloma

scientific article published on 21 October 2019

Delineation of the timing of second line therapy post- autologous stem cell transplant in patients with AL amyloidosis

scientific article published on 14 August 2017

Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia

scientific article published on 08 August 2017

Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016.

scientific article published on 05 January 2017

Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?

article by Eli Muchtar et al published 12 March 2018 in Amyloid

Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials

scientific article published on 11 August 2017

Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation

scientific article

Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie

scientific article

Fifty-Year Incidence of Waldenström Macroglobulinemia in Olmsted County, Minnesota, From 1961 Through 2010: A Population-Based Study With Complete Case Capture and Hematopathologic Review

scientific article published on 12 April 2018

First report of MYD88 L265P somatic mutation in IgM-associated light-chain amyloidosis.

scientific article published on 31 March 2016

First report of MYD88L265P somatic mutation in IgM-associated light chain amyloidosis

Hematologic characteristics of proliferative glomerulonephritides with nonorganized monoclonal immunoglobulin deposits

scientific article published on May 2015

Hematology patient reported symptom screen to assess quality of life for AL amyloidosis

scientific article published on 9 February 2017

Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes

scientific article published on 29 August 2019

Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival

Immunoparesis status in AL amyloidosis at diagnosis affects response and survival by regimen type

Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type

scientific article published on 16 June 2016

Impact of MYD88L265P mutation status on histological transformation of Waldenström Macroglobulinemia

scientific article published on 31 December 2019

Impact of Post-Transplant Response and Minimal Residual Disease on Survival in Myeloma with High-Risk Cytogenetics.

scientific article published on 20 January 2017

Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis

scientific article published on 23 July 2019

Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation.

scientific article published on 29 April 2018

Impact of pre-transplant bone marrow plasma cell percentage on post-transplant response and survival in newly diagnosed multiple myeloma.

scientific article published on 7 July 2016

Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone

scientific article published on 26 March 2009

Implications of MYC Rearrangements in Newly Diagnosed Multiple Myeloma

scientific article published on 02 October 2020

Implications of continued response after autologous stem cell transplantation for multiple myeloma

scientific article published on 17 July 2013

Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma

scientific article published on 20 November 2020

Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma

scientific article

Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death

scientific article published on 26 January 2017

Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients

scientific article published on 07 April 2020

Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis

scientific article published on 01 May 2018

Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation.

scientific article published on 24 June 2016

Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation

scientific article published on 01 April 2018

Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience

scientific article published on 11 March 2016

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013.

scientific article published on April 2013

Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma

scientific article published on 01 May 2020

Multicentric Castleman disease – a single center experience of treatment with a focus on autologous stem cell transplantation

Myelomatous Involvement of the Central Nervous System

scientific article

N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma

scientific article published on 10 August 2016

Natural history of amyloidosis isolated to fat and bone marrow aspirate.

scientific article published on 22 June 2016

Natural history of multiple myeloma with de novo del(17p)

scholarly article by Arjun Lakshman et al published 7 March 2019 in Blood Cancer Journal

Outcome of very young (≤40 years) patients with immunoglobulin light chain (AL) amyloidosis

Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved

scientific article published on 02 May 2019

Outcomes of patients with POEMS syndrome treated initially with radiation

scientific article

Outcomes of patients with renal monoclonal immunoglobulin deposition disease

scientific article published on 8 August 2016

Outcomes of primary refractory multiple myeloma and the impact of novel therapies

scientific article published on 27 July 2015

Outcomes with different administration schedules of Bortezomib in Bortezomib, Lenalidomide and dexamethasone (VRd) as first-line therapy in Multiple Myeloma

scientific article published on 16 December 2020

Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma

scientific article published on 12 March 2019

Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome

scholarly article by Ashley R Paquin et al published 11 December 2018 in Blood Cancer Journal

Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognition

scientific article published on 8 March 2017

Partial response or better at six months is prognostic of superior progression-free survival in Waldenström macroglobulinaemia patients treated with ibrutinib

scientific article published on 18 November 2020

Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma

scientific article published on 30 July 2018

Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma

article published in 2018

Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete response

scientific article published on 07 August 2018

Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantation.

scientific article published on 19 April 2018

Pomalidomide, Bortezomib and Dexamethasone (PVD) for Patients with Relapsed, Lenalidomide Refractory Multiple Myeloma

scientific article

Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myeloma

scientific article published on 6 July 2015

Predictors of early treatment failure following initial therapy for systemic immunoglobulin light-chain amyloidosis

scientific article

Predictors of short-term survival in Waldenström Macroglobulinemia

scientific article published on 14 July 2020

Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic Experience

scientific article published on 5 May 2017

Primary systemic amyloidosis in patients with Waldenström macroglobulinemia

scientific article published on 12 October 2018

Prognostic Role of Beta-2 Microglobulin in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell Transplantation

scientific article published on 15 May 2020

Prognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosis

scientific article published on 02 February 2019

Prognostic Significance of Stringent Complete Response after Stem Cell Transplantation in Immunoglobulin Light Chain Amyloidosis

scientific article published on 30 June 2018

Prognostic significance of circulating plasma cells by multi-parametric flow cytometry in light chain amyloidosis.

scientific article published on 21 February 2018

Prognostic value of NT-ProBNP and troponin T in patients with light chain amyloidosis and kidney dysfunction undergoing autologous stem cell transplantation

scientific article published on 04 July 2020

Quantification of clonal circulating plasma cells in relapsed multiple myeloma

scientific article

Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib

scientific article published on 4 October 2016

Retroperitoneal involvement with light chain amyloidosis- case series and literature review

scientific article published on 29 October 2020

Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myeloma

scholarly article by Praful Ravi et al published 15 November 2018 in Blood Cancer Journal

Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma

scientific article published in January 2018

Serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autologous transplantation

scientific article published on 4 May 2017

Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T.

scientific article

Stem Cell Transplantation for Light Chain Amyloidosis: Decreased Early Mortality Over Time.

scientific article published on 20 March 2018

Substratification of patients with newly diagnosed standard-risk multiple myeloma

scientific article published on 15 February 2019

Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome

scientific article published on October 2016

Ten-year survivors in AL amyloidosis: characteristics and treatment pattern

scientific article published on 12 July 2019

The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantation

scientific article published on 30 November 2015

The impact of re-induction prior to salvage autologous stem cell transplantation in multiple myeloma

scientific article published on 12 June 2019

The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma

scientific article published on 10 March 2016

The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myeloma

scientific article published on 31 May 2017

The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment

scientific article

Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy

scientific article published on 10 March 2017

Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia

scientific article published on 15 October 2020

Treatment of Immunoglobulin Light Chain Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement

scientific article published on August 2015

Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosis

scientific article published on 17 March 2017

Trends and outcomes in allogeneic hematopoietic stem cell transplant for multiple myeloma at Mayo Clinic

scientific article published on 02 April 2015

Trends in survival of patients with primary plasma cell leukemia: a population-based analysis

scientific article

Use of Beta Blockers is Associated with Survival Outcome of Multiple Myeloma Patients Treated with Pomalidomide

scientific article published on 01 December 2020

Utility of repeating bone marrow biopsy for confirmation of complete response in multiple myeloma

scientific article published on 02 October 2020

Utility of serum free light chain ratio in response definition in patients with multiple myeloma

scientific article published on 01 January 2020

Paulina is supported by:

About Paulina

Help